- Home
- XWIN vs FENC Comparison
XWIN vs FENC Comparison
Compare XWIN & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XWIN | FENC |
|---|---|---|
| Founded | 2003 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.1M | 263.3M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | XWIN | FENC |
|---|---|---|
| Price | $6.20 | $7.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 580.3K | 116.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 96.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $47,538,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $70.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 123.69 |
| 52 Week Low | $5.20 | $4.68 |
| 52 Week High | $6.39 | $9.92 |
Technical Indicators
Market Signals| Indicator | XWIN | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 55.94 | 35.66 |
| Support Level | $5.53 | N/A |
| Resistance Level | $6.36 | $8.09 |
| Average True Range (ATR) | 0.13 | 0.44 |
| MACD | -0.01 | -0.15 |
| Stochastic Oscillator | 51.79 | 7.41 |
Price Performance
Historical ComparisonAbout XWIN XMAX Inc.
XMax Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.